iBio, Inc.
IBIO
$0.85
$0.000.53%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 45.73% | 30.36% | 29.25% | 56.01% | 61.69% |
| Total Depreciation and Amortization | -31.84% | -34.07% | -3.29% | 1.59% | 15.00% |
| Total Amortization of Deferred Charges | -- | -100.00% | -100.00% | -89.73% | -50.41% |
| Total Other Non-Cash Items | -86.46% | 45.67% | -9.20% | -65.02% | -70.23% |
| Change in Net Operating Assets | 79.83% | -211.29% | -314.90% | -141.78% | -153.98% |
| Cash from Operations | 34.25% | 33.38% | 14.80% | 22.40% | 39.04% |
| Capital Expenditure | 99.05% | 58.30% | 30.82% | 93.56% | 96.73% |
| Sale of Property, Plant, and Equipment | -- | -88.00% | -97.51% | -97.51% | -95.54% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -24.20% | -28.80% | -71.18% | -77.58% | -90.77% |
| Cash from Investing | -16.56% | -45.69% | -81.09% | -77.68% | -87.07% |
| Total Debt Issued | -- | -100.00% | -- | 79.00% | 79.00% |
| Total Debt Repaid | 74.47% | 6.80% | 56.02% | 83.66% | 78.88% |
| Issuance of Common Stock | -90.54% | -4.67% | 27.49% | 70.21% | 123.97% |
| Repurchase of Common Stock | -- | 100.00% | 100.00% | 82.05% | 82.05% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 6,863.64% | -- | -- | -300.00% | -300.00% |
| Cash from Financing | -67.89% | -10.98% | 65.74% | 501.87% | 964.49% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -152.25% | 124.08% | 2,763.06% | 158.44% | 132.46% |